What novel therapies are on the horizon for metastatic renal cell carcinoma? 2019 and beyond
Kidney Cancer
The speaker emphasizes that while general risk factors like the number of prior treatments significantly influence patient outcomes, individual molecular details often dictate which specific therapies are most effective. A key argument presented is that treating all kidney cancers uniformly ignores …